 |
 |

Maintaining Low HIV Seroprevalence Among Injecting Drug Users
Clive L. Morrison, MB, ChB
The Maryland Centre
Susan M. Ruben, MB, ChB, MRCPsych
The Liverpool Drug Dependency Clinic Liverpool, England
JAMA. 1996;275(8):596-597.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.
—Dr Des Jarlais and colleagues1 have concluded that as a result of establishing HIV prevention measures (needle exchange, outreach) for drug users, some cities have escaped from epidemic levels of HIV in IDUs and that simply the continued existence of such facilities will avert a future epidemic. Their conclusion is based on the observation that those cities with established HIV prevention measures currently have low HIV rates in the IDU population. The authors, how
ever, assume rather than test any relationship between establishing HIV prevention measures and low-risk behavior in the associated drug-using community. In effect, their report has failed to include important performance indicators and outcome measures of health care provision to IDU populations by concentrating on the HIV infection incidence alone; a more relevant and predictive indicator would be to measure sharing risk. Health policy in England has recognized this and has set targets
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|